With a number of difference payment programs being tested, it’s important to have a sophisticated evaluation of these programs to really understand their impact on quality and cost, said Allison Brennan, MPP, senior vice president of government affairs for the National Association of ACOs.
With a number of difference payment programs being tested, it’s important to have a sophisticated evaluation of these programs to really understand their impact on quality and cost, said Allison Brennan, MPP, senior vice president of government affairs for the National Association of ACOs.
Transcript
How have accountable care organizations (ACOs) compared with other payment models when it comes to improving care and reducing costs?
So, there are definitely a number of payment models out there. One thing that we’ve emphasized with the ACO programs is the need to have a sophisticated evaluation of these programs. So, we need to look beyond just the performance of the ACO relative to their CMS benchmark. And we’ve actually recently put out data that does show significant savings for the MSSP program, similarly CMMI {Center for Medicare and Medicaid Innovation] has done sophisticated analyses on the first year of the Next Generation ACO model, which also showed significant savings.
As we look at other CMMI programs, it’s really important to use similar types of evaluations as we look across programs. That will allow us to have kind of similar results or comparisons that are on even playing fields. And a lot of these programs are still relatively new, so we need a few years of data before we can really draw conclusions.
But we have seen strong performance in data from ACOs in terms of cost reductions and quality. In some other programs we’ve seen kind of one or the other or sometimes we see improvements in quality and cost kind of neutral, but maybe when we factor in the additional payments to those programs then it’s not a net savings to Medicare. So, I think that overall in comparison to other programs, ACOs are showing increasingly positive results.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Cost Barriers Continue to Limit Access to Fertility Care
October 24th 2024Of the 10% of women contacted for this survey who said that they or their partner had ever sought fertility assistance, only 7% were able to get the necessary care; cost was cited as the top reason for not being able to access fertility services.
Read More